Sites for clinical trials should be evaluating patient access and monitoring during clinical trials. However, when performing trials, they ought to take long-term changes into account. Sponsors can guarantee patient security and enjoy equal or greater visibility into site operations. A clinical trial design that is quickly carried out and uses Veristat cutting-edge technologies can produce comparable outcomes. This means future trials will be quicker and more accurate. Now is the best time to start this conversation because CROs and sponsors are ready to work together and regain essential access to a research site’s papers and source data.
Remote monitoring can help researchers reach their research objectives more effectively. Thus, it benefits those who participate in the clinical trial. Teams will be prepared to respond to an ever-changing environment changing a lot faster than before. Regulators are pushing for remote monitoring and advocating it. Digitizing and simplifying clinical trial processes offer considerable advantages which include;
Enhanced data quality
Clinical trial planning could involve a large amount of paper documentation. Clinical research associates (CRAs) might well be typing data into hundreds of files while manually examining them. This gives the source data verification process room for error or discrepancies. In addition, data monitoring, collection, and reporting processes can be automated with the use of a CTMS (clinical trial management system). Integrating subject data has the potential to eliminate errors. Audit trails can demonstrate activities made on various records for accountability and integrity.
Increased access to patients
Primary care physicians can recruit volunteers for clinical trials from more places if they are not geographically constrained. Telehealth can be used exclusively or partially in decentralized trials. Patient participation is facilitated by technology such as mobile apps and connected gadgets. As such, patients don’t have to leave their homes to participate in trials.
The paperless filing system allows CRAs to collect and organize documents with less effort. Even while some research communications now take place over email, they are still largely distributed. CRAs could also keep track of phone calls and attachments. Collaboration can even increase, communication will be centralized, and paperless trial administration will be possible. Project calendars can be used to automate and track activities, milestones, and workflows. The gathering and reporting of information are becoming increasingly standardized.
Overall, clinical trials are costly, and some of those expenses are specifically connected to onsite monitoring. CRAs alone can have high transportation costs. Additionally, there are site expenses for office space and technology. If CRAs devote less time to monitoring paper and trial data, costs can also decrease. This might also result in fewer staff requirements or a quicker trial schedule. Providing more therapy to patients sooner may be possible because of time and money savings. Clinical trials frequently experience issues with CRA burnout and turnover. Reduced reliance on laborious data entry and travel will lower turnover. The cost savings will increase as a result.
Remote monitoring has its advantages. But the emergence of the pandemic prompted the adoption of remote monitoring. Thus, the technology is already available and ready for use. Even then, then you have the power to make the decision depending on your own needs as well as the evolving perks for your study partners. The most important lesson here is to make sure that the option you go with is focused on the specific workflows and requirements of the study site.